CHCT's Eighteen-Month Wait Ends Without a Deal — and the Stock Already Paid for It
A clean third quarter, a $99 million acquisition pipeline and one expired letter of exclusivity: Community Healthcare Trust's growth now hinges on recycling capital faster than the Fed can tax it.
CHCT · Earnings Call · 2026-11-04
An okay quarter against a terrible tape
By its own accounting, Community Healthcare Trust just posted its best operating quarter in years. Revenue rose to $32.4 million from $31.1 million, a 4.4% increase; FFO climbed 10.4% to $15.0 million, or $0.54 per diluted share versus $0.50; AFFO reached $16.0 million, $0.58 a share. The cost side was the real tell: property operating expenses rose less than $50,000 year over year, and G&A fell roughly $470,000 to $4.2 million — management calls that a new run-rate. Occupancy ticked from 89.8% to 90.1%, leverage fell 0.2x to 5.8x, and the company issued no ATM shares and drew nothing incremental on the revolver.Operating cash flow of $18 million, up 27% year over year is not the profile of a business in distress. The stock disagrees. CHCT is down 20.6% over the last 90 trading days in a single unbroken descent — a price-to-earnings multiple that has collapsed from a 2021 peak — finishing 23.7% below its July 28 high of $19.02 and 72.2% beneath the $52.22 touched in April 2021. A good quarter into a bad tape is not a contradiction; it is the point. The gap between those two paragraphs is the whole story of this call.Exclusivity expires: the one thing that actually changed
The geriatric behavioral hospital operator that leases six CHCT properties has been the portfolio's live grenade for a year and a half. On this call the tenant paid roughly $540,000 of rent, up $170,000 sequentially — the third straight quarter of recovery. But the transaction to sell that operator's business to a new sponsor, and re-paper the six leases with CHCT, has now lost its exclusive window.That is a genuine posture change, and the prior transcripts make it legible. In October 2025 the timeline was concrete: “it's probably more realistic to expect something to close in the first quarter” — David Dupuy, Chief Executive Officer · 2025-10-29 — i.e., Q1 2026. By August 2026 the tone was still confident: “we feel confident that ultimately they're going to end up being the buyer” — David Dupuy, Chief Executive Officer · 2026-08-05. Three months later the prospective buyer is one of several again, and management is openly re-engaging parties who circled earlier. The keyword is new to the top ranks this quarter, and so is the word frustrated. Why it matters more than the income statement: this tenant sits inside the top-10 concentration list, its rent is still below contractual levels, and the notes receivable against it were reserved long ago. Resolution is pure upside; non-resolution is a permanent discount. The call did not resolve it — it re-opened it.Their exclusivity has expired. The performance of the business, the underlying business is doing much better today than when the LOI was signed 18 months or so ago... given the fact that it's taken longer and quite frankly, we're a little bit frustrated with the length of time and the amount of due diligence... we just think it's in the best interest of us and frankly, the tenant to not have all the eggs in this basket.
Recycling capital faster than the Fed can eat it
With no equity currency, the growth engine is now buy-high-yield, sell-lower-yield. CHCT monetized one property in Q3 and two more in October for $32.8 million of net proceeds; the largest, an inpatient rehab facility, throws off a $9.1 million gain in Q4 and is being rolled through a Section 1031 exchange into another rehab asset. More than $30 million is actively marketed. Against that, four properties are under definitive purchase agreements for roughly $99 million at 9.1%–9.75% returns, closing between Q4 and early 2028.That spread is the entire thesis, and it is not subtle. The company sells at roughly a 7.9% cap — “we received an indicative 7.9% cap rate on the sale of inpatient rehab” — William Monroe · 2026-02-18, Bill Monroe said in February — and buys in the 9% to 10% band. “That mid-9 range, anywhere from 9% to 10% is achievable” — David Dupuy, Chief Executive Officer · 2026-11-04, Dave Dupuy said this quarter. It is a sound arbitrage and it is also a treadmill: strategic capital recycling has been the company's defining phrase for two years because it is the only funding source that does not require the share price to cooperate. What it cannot outrun is the cost of debt. Interest expense of $7 million, up 13% year over year and roughly 466% over three years now consumes a fifth of revenue. Liabilities at 58.7% of assets, up 14 points in a year and interest coverage of 2.9x versus a 3.5x peak frame the constraint. Monroe was explicit about the culprit: “the FOMC decision in mid-September to raise interest rates by 25 basis points” — William Monroe, Chief Financial Officer · 2026-11-04. That the market's own top themes this quarter include Fed rate hike and the impact of high rates tells you CHCT is not fighting a private problem — and the market tape has already voted on higher cost of capital, a global 360-day decliner led by a European warehouse REIT. Unsurprisingly, expense increased is the single highest-ranked keyword in CHCT's own third-quarter set.It has been a very robust process on both of those larger inpatient rehab facilities we've sold. And I think the gains associated with those sales give credence to the fact that there's certainly a dislocation between where we're valued from a public markets perspective and what the private market views as attractive real estate.